No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Aminopeptidase N (APN) is a type of enzyme that plays a role in the metabolism of hematological drugs. It is involved in the breakdown of peptides and proteins, and is found in the liver, kidney, and other organs. APN inhibitors are used to increase the bioavailability of hematological drugs, allowing them to be more effective. APN inhibitors can also be used to reduce the side effects of hematological drugs, such as nausea and vomiting.
The APN pipeline market is composed of a variety of companies that are developing inhibitors for hematological drugs. These companies are researching and developing new inhibitors that can be used to increase the effectiveness of hematological drugs. Companies in the APN pipeline market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
